Mail

UK markets closed

FTSE 100
7,895.85
+18.80(+0.24%)
FTSE 250
19,391.30
-59.37(-0.31%)
AIM
745.67
+0.38(+0.05%)
GBP/EUR
1.1607
-0.0076(-0.65%)
GBP/USD
1.2370
-0.0068(-0.55%)
Bitcoin GBP
52,030.04
+690.00(+1.34%)

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

JCR Pharmaceuticals Co., Ltd. (4552.T)

Tokyo - Tokyo Delayed price. Currency in JPY

Add to watchlist

781.00

-18.00

(-2.25%)

At close: 03:15PM JST

Currency in JPY

Valuation measures⁴

Market cap (intra-day)	99.72B
Enterprise value	104.72B
Trailing P/E	18.68
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.42
Price/book (mrq)	1.79
Enterprise value/revenue	2.53
Enterprise value/EBITDA	13.82

Trading information

Stock price history

Beta (5Y monthly)	-0.01
52-week change ³	-45.39%
S&P500 52-week change ³	21.23%
52-week high ³	1,567.00
52-week low ³	778.00
50-day moving average ³	882.10
200-day moving average ³	1,143.98

Share statistics

Avg vol (3-month) ³	745.52k
Avg vol (10-day) ³	508.97k
Shares outstanding ⁵	124.8M
Implied shares outstanding ⁶	125.11M
Float ⁸	73.38M
% held by insiders ¹	43.26%
% held by institutions ¹	17.50%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	20
Forward annual dividend yield ⁴	2.50%
Trailing annual dividend rate ³	20.00
Trailing annual dividend yield ³	2.50%
5-year average dividend yield ⁴	0.86
Payout ratio ⁴	46.76%
Dividend date ³	N/A
Ex-dividend date ⁴	28 Mar 2024
Last split factor ²	4:1
Last split date ³	30 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Mar 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	12.97%
Operating margin (ttm)	9.64%

Management effectiveness

Return on assets (ttm)	5.03%
Return on equity (ttm)	9.93%

Income statement

Revenue (ttm)	41.37B
Revenue per share (ttm)	331.61
Quarterly revenue growth (yoy)	-15.00%
Gross profit (ttm)	N/A
EBITDA	9.87B
Net income avi to common (ttm)	5.36B
Diluted EPS (ttm)	42.75
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	18.3B
Total cash per share (mrq)	146.64
Total debt (mrq)	23.3B
Total debt/equity (mrq)	41.65%
Current ratio (mrq)	1.80
Book value per share (mrq)	445.92

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A